CREBBP and colorectal carcinoma: Furthermore, ATRA and vitamin D, through their associated nuclear receptors, counteract abnormal Wnt signaling in colorectal carcinoma cells [1, 15], thereby mechanistically phenocopying CBP/catenin antagonists in their competitive binding to CBP’s N-terminal region.